DENVER, Aug. 23, 2016 /PRNewswire/ -- DaVita Kidney Care, a division of DaVita HealthCare Partners Inc. (NYSE: DVA), and a leading independent provider of integrated health and kidney care services in the United States, welcomes Jeffrey Allen Giullian, MD, MBA, as a vice president of medical affairs and member of the Office of the Chief Medical Officer, DaVita's physician leadership team. Dr. Giullian will hold the position of national group medical director and will also be the clinical leader for the Hospital Services Group.

"Jeff has been an integral and passionate leader in our educational program for chronic kidney disease patients," said Allen R. Nissenson, MD, FACP, chief medical officer for DaVita Kidney Care. "In addition, we expect his work with our hospital services group will identify ways we can better serve patients with acute kidney injury and help standardize practices in our hospital settings."

Dr. Giullian graduated from Vanderbilt University where he trained in both transplantation and nephrology. He is currently a member of the board of directors for the Renal Physician Association (RPA). He is vice chairman of the healthcare payment committee for RPA and advisor to the American Medical Association's relative value unit utilization committee. In the past, he was chairman of medicine at a community hospital in Denver. Dr. Giullian has been a group medical director at DaVita since 2014 and was a practicing nephrologist for eight years in Denver.

Dr. Giullian has stated "care delivery can be value-based and streamlined by focusing on operational efficiency and partnerships." His aim is to improve best practices and work with others in the healthcare community to provide value based healthcare for all patients. Dr. Giullian also has a passion for increasing patient education and public understanding of chronic kidney disease and has spoken over 250 times both in lectures and at national meetings.  

About DaVita Kidney Care
DaVita Kidney Care is a division of DaVita HealthCare Partners Inc., a Fortune 500® company that, through its operating divisions, provides a variety of health care services to patient populations throughout the United States and abroad. A leading provider of dialysis services in the United States, DaVita Kidney Care treats patients with chronic kidney failure and end stage renal disease. DaVita Kidney Care strives to improve patients' quality of life by innovating clinical care, and by offering integrated treatment plans, personalized care teams and convenient health-management services. As of June 30, 2016, DaVita Kidney Care operated or provided administrative services at 2,293 outpatient dialysis centers located in the United States serving approximately 185,000 patients. The company also operated 127 outpatient dialysis centers located in 11 countries outside the United States. DaVita Kidney Care supports numerous programs dedicated to creating positive, sustainable change in communities around the world. The company's leadership development initiatives and social responsibility efforts have been recognized by Fortune, Modern Healthcare, Newsweek and WorldBlu. For more information, please visit DaVita.com.

DaVita and DaVita HealthCare Partners are trademarks or registered trademarks of DaVita HealthCare Partners Inc.

Contact Information



Media:

Lindsey Robinson


Lindsey.Robinson@DaVita.com


720.401.5616

 

DaVita logo. (PRNewsFoto/DaVita)

 

Logo - http://photos.prnewswire.com/prnh/20160822/400295LOGO

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/davita-kidney-care-welcomes-dr-jeff-giullian-to-physician-leadership-team-300316775.html

SOURCE DaVita Kidney Care

Copyright 2016 PR Newswire

DaVita (NYSE:DVA)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more DaVita Charts.
DaVita (NYSE:DVA)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more DaVita Charts.